BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 902141)

  • 1. Phosphatase content of rat calvaria after in vivo administration of vitamin D3 metabolites.
    Lieberherr M; Pezant E; Garabedian M; Balsan S
    Calcif Tissue Res; 1977 Oct; 23(3):235-9. PubMed ID: 902141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of aluminum on bone phosphatases: a possible interaction with bPTH and vitamin D3 metabolites.
    Lieberherr M; Grosse B; Cournot-Witmer G; Thil CL; Balsan S
    Calcif Tissue Int; 1982 May; 34(3):280-4. PubMed ID: 6809290
    [No Abstract]   [Full Text] [Related]  

  • 3. 1,25-Dihydroxycholecalciferol effect on serum phosphorus homeostasis in rats.
    Garabedian M; Pezant E; Miravet L; Fellot C; Balsan S
    Endocrinology; 1976 Mar; 98(3):794-9. PubMed ID: 1261499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of 24,25-dihydroxyvitamin D3 and parathyroid hormone on bone enzymes in vitro.
    Lieberherr M; Garabédian M; Guillozo H; Bailly du Bois M; Balsan S
    Calcif Tissue Int; 1979 Mar; 27(1):47-52. PubMed ID: 111787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological activity of synthetic 25,26-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in vitamin D-deficient rats.
    Miravet L; Redel J; Carre M; Queillé ML; Bordier P
    Calcif Tissue Res; 1976 Dec; 21(3):145-52. PubMed ID: 1000334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of 24,25-dihydroxycholecalciferol in chicks and rats.
    Henry HL; Norman AW; Taylor AN; Hartenbower DL; Coburn JW
    J Nutr; 1976 Jun; 106(6):724-34. PubMed ID: 178843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal response to 1 alpha, 25-dihydroxycholecalciferol. I. RNA polymerase, alkaline phosphatase, calcium and phosphorus uptake in vitro, and in vivo calcium transport and accumulation.
    Morrissey RL; Zolock DT; Bikle DD; Empson RN; Bucci TJ
    Biochim Biophys Acta; 1978 Jan; 538(1):23-33. PubMed ID: 620061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative effectiveness of vitamin D metabolites in increasing bone mineral solubility.
    Somerman MJ; Neuman WF
    Calcif Tissue Int; 1981; 33(2):159-65. PubMed ID: 6783272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of 1,25-dihydroxycholecalciferol on the ultrastructural organization of skeletal muscle fibres. Morphometric analyses on vitamin D deficient or calcium deficient growing rats.
    Sjŏstrŏm M; Lorentzon R; Larsson SE; Holmlund D
    Med Biol; 1978 Aug; 56(4):209-15. PubMed ID: 703405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3.
    Haussler MR; Zerwekh JE; Hesse RH; Rizzardo E; Pechet MM
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2248-52. PubMed ID: 4365368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased bone sensitivity of thyroidectomized rats to the calcaemic effect of 1,25-dihydroxycholecalciferol.
    Pavlovitch H; Presle V; Balsan S
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):774-9. PubMed ID: 576761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats.
    Pavlovitch JH; Cournot-Witmer G; Bourdeau A; Balsan S; Fischer JA; Heynen G
    J Clin Invest; 1981 Sep; 68(3):803-810. PubMed ID: 6974178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vitamin D3 metabolites on bone cell calcium transport.
    Dziak R
    Calcif Tissue Res; 1978 Nov; 26(1):65-70. PubMed ID: 216471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone changes in rats with adjuvant arthritis: treatment with 1 alpha-hydroxycholecalciferol.
    Binderup L
    Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):228-35. PubMed ID: 3799201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.
    Favus MJ; Walling MW; Kimberg DV
    J Clin Invest; 1973 Jul; 52(7):1680-5. PubMed ID: 4718960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol.
    Boyle IT; Gray RW; DeLuca HF
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2131-4. PubMed ID: 4332247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parathyroid gland adenylate cyclase activity: inhibition by 24,25-dihydroxycholecalciferol in vitro.
    Cloix JF; Ulmann A; Monet JD; Funck-Brentano JL
    Clin Sci (Lond); 1981 Mar; 60(3):339-41. PubMed ID: 6972285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
    Blazhevich NV; Sergeev IN; Arkhapchev IuP; Isaeva VA; Spirichev VB
    Vopr Med Khim; 1982; 28(6):98-105. PubMed ID: 6297167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.